ProtAffin initiates Phase 1 study of anti-inflammatory product
ProtAffin, a biotechnology company, has commenced dosing healthy volunteers in a Phase 1 study of PA401, in the UK.
PA401, the novel investigational anti-inflammatory product, is a modified form of the human chemokine IL-8.
By acting as a potent, targeted anti-inflammatory protein, PA401 prevents the infiltration of neutrophils which is a feature of many respiratory diseases such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF).
ProtAffin chief development officer Mike Bartley said, "Our extensive preclinical studies into the anti-inflammatory properties of PA401 suggest that it is a promising candidate for the steroid-resistant inflammation which causes significant morbidity and mortality in diseases such as COPD and cystic fibrosis. We expect to complete the study by the end of 2012."
ProtAffin chief executive officer Jason Slings said PA401 was discovered using ProtAffin's proprietary CellJammer discovery platform.
"We are confident that we will establish targeting glycans with biopharmaceuticals as a new therapeutic modality within the biopharmaceuticals industry," Slings added.
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" is a crucial resource for industry executives and anyone looking to access key information about "UnitedHealth Group Incorporated" ICD Research's "UnitedHealth Group Incorporated: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $125